US Patent Issued to A2 Biotherapeutics on Oct. 7 for "Compositions and methods for treating CEACAM positive cancers" (California Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,124, issued on Oct. 7, was assigned to A2 Biotherapeutics Inc. (Agoura Hills, Calif.).

"Compositions and methods for treating CEACAM positive cancers" was invented by Xueyin Wang (Agoura Hills, Calif.), Carl Alexander Kamb (Agoura Hills, Calif.), Han Xu (Agoura Hills, Calif.), Mark L. Sandberg (Agoura Hills, Calif.) and Dora Toledo Warshaviak (Agoura Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides immune cells comprising a first activator receptor specific to CEA, and a second inhibitory receptor, and methods of making and using same for the treatment of cancer."

The patent was filed on July 22, 2022, under Appli...